Acuamark Diagnostics: Giulia Kennedy

Cancer testing firm Acuamark Diagnostics has appointed Giulia Kennedy to its board of directors. She is former CSO and chief medical officer of cancer genetics company Veracyte. Prior to that, she was with Affymetrix. William Gedale, executive chairman of New York City-based Acuamark, said in a statement that Kennedy's diverse experience in diagnostics and expertise in attracting capital and driving commercial development are essential to this phase of Acuamark's growth.